Since 2010, he has been working as research materials scientist at the Center for Devices and Radiological Health (CDRH) in the US Food and Drug Administration. His areas of research are investigating how the additive manufacturing process can affect device performance, the interplay between corrosion and durability testing, and explant analysis. Along with his research duties, he was the Chair of the FDA Advanced Manufacturing Technologies Working Group until 2023, which is spearheading efforts across the Agency to address how advanced manufacturing technologies affects regulated medical products. He is also the Chair of the CDRH Additive Manufacturing Working Group which leading efforts across the Center on how additive manufacturing affects medical device performance. These efforts include guidance and standards development, device review harmonization, and performing regulatory science with the intent to foster innovative and high-quality products while maintaining they have the same safety and effectiveness that Americans have come to expect. He is also active in standards development and is co-Chair of ASTM F42.07.03, Additive Manufacturing Applications: Medical/Biological.